These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 34767740)

  • 1. Chemotherapy plus concurrent irreversible electroporation improved local tumor control in unresectable hilar cholangiocarcinoma compared with chemotherapy alone.
    Ma Y; Chen Z; Zhu W; Yu J; Ji H; Tang X; Yu H; Fan L; Liang B; Li R; Li J; Li Z; Lin M; Niu L
    Int J Hyperthermia; 2021; 38(1):1512-1518. PubMed ID: 34767740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous Irreversible Electroporation of Unresectable Hilar Cholangiocarcinoma (Klatskin Tumor): A Case Report.
    Melenhorst MC; Scheffer HJ; Vroomen LG; Kazemier G; van den Tol MP; Meijerink MR
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):117-21. PubMed ID: 25994516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of irreversible electroporation ablation for unresectable hilar cholangiocarcinoma.
    Hsiao CY; Yang PC; Li X; Huang KW
    Sci Rep; 2020 Jul; 10(1):10883. PubMed ID: 32616770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy.
    Belfiore MP; Reginelli A; Maggialetti N; Carbone M; Giovine S; Laporta A; Urraro F; Nardone V; Grassi R; Cappabianca S; Brunese L
    Med Oncol; 2020 Apr; 37(5):45. PubMed ID: 32270353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of irreversible electroporation in unresectable perihilar cholangiocarcinoma: a systematic review and meta-analysis.
    Scrofani AR; Valvano M; Lancellotta V; Pezzulla D; Vinci A; Cornacchione P; Bonome P; Tagliaferri L; Iezzi R
    Br J Radiol; 2024 Aug; 97(1160):1413-1422. PubMed ID: 38775716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma.
    Park DH; Lee SS; Park SE; Lee JL; Choi JH; Choi HJ; Jang JW; Kim HJ; Eum JB; Seo DW; Lee SK; Kim MH; Lee JB
    Eur J Cancer; 2014 May; 50(7):1259-68. PubMed ID: 24485665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gemcitabine plus concurrent irreversible electroporation
    Ma YY; Leng Y; Xing YL; Li HM; Chen JB; Niu LZ
    World J Clin Cases; 2020 Nov; 8(22):5564-5575. PubMed ID: 33344547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Irreversible Electroporation for Perihilar Cholangiocarcinoma: A Prospective Pilot Study.
    Franken LC; van Veldhuisen E; Ruarus AH; Coelen RJS; Roos E; van Delden OM; Besselink MG; Klümpen HJ; van Lienden KP; van Gulik TM; Meijerink MR; Erdmann JI
    J Vasc Interv Radiol; 2022 Jul; 33(7):805-813.e1. PubMed ID: 35346858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol.
    Coelen RJS; Vogel JA; Vroomen LGPH; Roos E; Busch ORC; van Delden OM; Delft FV; Heger M; van Hooft JE; Kazemier G; Klümpen HJ; van Lienden KP; Rauws EAJ; Scheffer HJ; Verheul HM; Vries J; Wilmink JW; Zonderhuis BM; Besselink MG; van Gulik TM; Meijerink MR
    BMJ Open; 2017 Sep; 7(9):e015810. PubMed ID: 28864693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of irreversible electroporation in the treatment of obstructive jaundice in advanced hilar cholangiocarcinoma.
    Martin EK; Bhutiani N; Egger ME; Philips P; Scoggins CR; McMasters KM; Kelly LR; Vitale GC; Martin RCG
    HPB (Oxford); 2018 Nov; 20(11):1092-1097. PubMed ID: 30057125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Irreversible Electroporation (IRE) of Hepatic Malignancy: A Bi-institutional Analysis of Safety and Outcomes.
    Mafeld S; Wong JJ; Kibriya N; Stenberg B; Manas D; Bassett P; Aslam T; Evans J; Littler P
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):577-583. PubMed ID: 30465255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
    van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
    J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible Electroporation to Treat Unresectable Colorectal Liver Metastases (COLDFIRE-2): A Phase II, Two-Center, Single-Arm Clinical Trial.
    Meijerink MR; Ruarus AH; Vroomen LGPH; Puijk RS; Geboers B; Nieuwenhuizen S; van den Bemd BAT; Nielsen K; de Vries JJJ; van Lienden KP; Lissenberg-Witte BI; van den Tol MP; Scheffer HJ
    Radiology; 2021 May; 299(2):470-480. PubMed ID: 33724066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible electroporation in locally advanced pancreatic cancer.
    Polyakov AN; Patyutko YI; Kudashkin NE; Kantieva DM; Romanova KA; Nasonova EA; Korshak AV; Egenov OA; Podluzhnyi DV
    Khirurgiia (Mosk); 2023; (10):29-38. PubMed ID: 37916555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
    Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
    BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
    Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.